bpc 157 human clinical trials status BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157: What you need to
Description
This group has also recently reported (2025) that intravenous administration of BPC 157 had no side-effects and was well-tolerated in two women
At the same time, online information about BPC-157 often ranges from outdated summaries to overly promotional claims that fail to distinguish experimental findings from established clinical evidence

However, IV therapy requires professional administration

Researchers are responsible for compliance with all applicable regulations governing peptide use in their jurisdiction